BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36280842)

  • 21. Serum total and HDL cholesterol and risk of prostate cancer.
    Mondul AM; Weinstein SJ; Virtamo J; Albanes D
    Cancer Causes Control; 2011 Nov; 22(11):1545-52. PubMed ID: 21915616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Ahn J; Moslehi R; Weinstein SJ; Snyder K; Virtamo J; Albanes D
    Int J Cancer; 2008 Sep; 123(5):1154-9. PubMed ID: 18546266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum β-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study.
    Karppi J; Kurl S; Laukkanen JA; Kauhanen J
    Nutr Cancer; 2012 Apr; 64(3):361-7. PubMed ID: 22420939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study.
    Guertin KA; Li XS; Graubard BI; Albanes D; Weinstein SJ; Goedert JJ; Wang Z; Hazen SL; Sinha R
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):945-952. PubMed ID: 28077427
    [No Abstract]   [Full Text] [Related]  

  • 26. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 28-year prospective analysis of serum vitamin E, vitamin E-related genetic variation and risk of prostate cancer.
    Lawrence WR; Lim JE; Huang J; Weinstein SJ; Mӓnnistӧ S; Albanes D
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):553-560. PubMed ID: 35197557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up.
    Virtamo J; Pietinen P; Huttunen JK; Korhonen P; Malila N; Virtanen MJ; Albanes D; Taylor PR; Albert P;
    JAMA; 2003 Jul; 290(4):476-85. PubMed ID: 12876090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
    Brasky TM; Darke AK; Song X; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA; Kristal AR
    J Natl Cancer Inst; 2013 Aug; 105(15):1132-41. PubMed ID: 23843441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.
    Albanes D; Weinstein SJ; Wright ME; Männistö S; Limburg PJ; Snyder K; Virtamo J
    J Natl Cancer Inst; 2009 Sep; 101(18):1272-9. PubMed ID: 19700655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and dietary vitamin E in relation to prostate cancer risk.
    Weinstein SJ; Wright ME; Lawson KA; Snyder K; Männistö S; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1253-9. PubMed ID: 17548693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial.
    Cheng TY; King IB; Barnett MJ; Ambrosone CB; Thornquist MD; Goodman GE; Neuhouser ML
    Am J Epidemiol; 2013 May; 177(10):1106-17. PubMed ID: 23535901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.
    Guasch-Ferré M; Hu FB; Ruiz-Canela M; Bulló M; Toledo E; Wang DD; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Lapetra J; Fitó M; Arós F; Serra-Majem L; Ros E; Dennis C; Liang L; Clish CB; Martínez-González MA; Salas-Salvadó J
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
    Chavarro JE; Stampfer MJ; Li H; Campos H; Kurth T; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1364-70. PubMed ID: 17585059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
    Albanes D; Heinonen OP; Taylor PR; Virtamo J; Edwards BK; Rautalahti M; Hartman AM; Palmgren J; Freedman LS; Haapakoski J; Barrett MJ; Pietinen P; Malila N; Tala E; Liippo K; Salomaa ER; Tangrea JA; Teppo L; Askin FB; Taskinen E; Erozan Y; Greenwald P; Huttunen JK
    J Natl Cancer Inst; 1996 Nov; 88(21):1560-70. PubMed ID: 8901854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
    Brändstedt J; Almquist M; Manjer J; Malm J
    Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum metabolomic profile of hair dye use.
    Lim JE; Huang J; Weinstein SJ; Parisi D; Mӓnnistö S; Albanes D
    Sci Rep; 2023 Mar; 13(1):3776. PubMed ID: 36882504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
    Kunutsor SK; Laukkanen JA
    Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pigmentation-related phenotypes and risk of prostate cancer.
    Weinstein SJ; Virtamo J; Albanes D
    Br J Cancer; 2013 Aug; 109(3):747-50. PubMed ID: 23860522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.